Project Grant R16AI201126
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Georgia Research Foundation, Inc. a $228,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period July 1, 2026 through June 30, 2028. The project, titled "Parasite Glycosylphosphatidylinositol Libraries: Expanding the Toolbox for Parasite Glycobiology," focuses on developing enzymatic pipelines and modular...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded a $436,750 Project Grant to the University of Georgia Research Foundation, Inc., effective July 3, 2026, with completion targeted for June 30, 2028. The research project, titled "Cellular and Molecular Profiling of Artemisinin-Induced Persister Phenotypes in P. Falciparum," will deliver cellular and...
- Federal Project Grant Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Washington University a Project Grant of $107,542 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period September 1, 2025, through August 31, 2027. The award supports investigator-initiated biomedical research examining the differential sorting and trafficking mechanisms of Plasmodium falciparum secreted proteins, with particular focus on how...
- Federal Grant Award Summary The University of Georgia Research Foundation, Inc. received a $650,020 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025, through July 31, 2030. This five-year research initiative will deliver investigative services focused on elucidating the mechanisms underlying memory regulatory T cell (mTreg)-mediated protection in...
- Federal Grant Award Summary Iowa State University of Science and Technology received a $385,816 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded July 24, 2025, with completion targeted for June 30, 2027. The research initiative focuses on identifying and characterizing proteases responsible for processing PREX—a polyprotein critical to apicoplast DNA replication in Plasmodium...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Kansas Center for Research Inc. a Project Grant of $411,499 under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 1, 2025, with completion scheduled for July 31, 2027. This research project seeks to establish poly(ADP-ribose) polymerase 14 (PARP14) as a novel host restriction factor that limits Herpes Simplex Virus 1 (HSV-1)...
- Federal Grant Award Summary Mercer University received a $230,463 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded July 3, 2026, with completion targeted for June 30, 2028. The research focuses on developing a novel multi-stage malaria vaccine antigen that targets multiple critical points in the Plasmodium parasite lifecycle. The project builds upon the institution's prior...
- Federal Project Grant Award Summary Georgia State University Research Foundation Inc. received a $6.68 million Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded August 18, 2025, with completion targeted for July 31, 2029. The project advances therapeutic candidates for seasonal and pandemic influenza treatment through development of prodrug conjugates of 4'-fluorouridine (4'-FLU),...
- Federal Grant Award Summary Kennesaw State University received a $529,359 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025 through August 31, 2028. The award supports fundamental research to develop next-generation deep eutectic solvents (DESs) for biomedical applications, specifically focusing on the stabilization and preservation of protein- and enzyme-based...
- Federal Grant Award Summary The University of South Florida received a $412,500 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 3, 2025 through June 30, 2027. The award supports research focused on evaluating immunodominant fragments of Plasmodium falciparum Glutamic Acid Rich Protein (PfGARP) for malaria vaccine development. The project builds on prior laboratory...
Kennesaw State University received a $144,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 13, 2026, with a completion date of June 30, 2030. The research project focuses on comparative mechanistic and structural analysis of phosphoethanolamine N-methyltransferases (PMTs) in apicomplexan parasites, which cause significant diseases including malaria, toxoplasmosis, and foodborne infections. The funded research will integrate comparative genomics, enzymology, biophysics, and mutagenesis to elucidate the catalytic mechanisms and ligand-recognition characteristics of PMTs from multiple parasite species including Plasmodium, Cyclospora, Toxoplasma, and Eimeria. The deliverables include structural characterization of apicomplexan PMTs utilizing artificial intelligence and machine learning-supported computational analysis with experimental validation to determine high-resolution protein structures and identify conserved versus variable ligand-binding regions. The ultimate outcome is to establish structure-function relationships that will identify potentially druggable binding pockets and enable development of selective small-molecule inhibitors for broad-spectrum and lineage-specific antiparasitic therapeutics. The project integrates well-established research methodologies with advanced instrumentation and provides research training opportunities for undergraduate and graduate students at the institution.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $144.0k | 7/13/26 |